Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16584
Country/Region: South Africa
Year: 2015
Main Partner: Beyond Zero
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $9,221,850 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,222,215
Care: Orphans and Vulnerable Children (HKID) $281,662
Care: TB/HIV (HVTB) $1,149,393
Care: Pediatric Care and Support (PDCS) $330,627
Laboratory Infrastructure (HLAB) $100,000
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $606,459
Treatment: Adult Treatment (HTXS) $4,471,047
Treatment: Pediatric Treatment (PDTX) $1,060,447
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 258,612
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 536,581
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 11,317
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 11,079
PMTCT_STAT By: Known positives at entry 2016 11,258
PMTCT_STAT Number of new ANC and L&D clients 2016 49,868
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 49,797
PMTCT_STAT Sum of Positives Status disaggregates 2016 11,258
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 258,612
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 183,676